The short version of Lyophilized powder fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-03-07 and is reviewed periodically as new material appears.
Most published studies examine BPC-157 in animal models rather than in humans. Common subjects include rats and mice, and researchers often use models of tissue injury, surgery, or induced inflammation. Reported endpoints include healing rates, blood vessel formation, and markers of tissue repair. These designs provide controlled comparisons, but findings in animals do not automatically transfer to people. Human clinical data remain limited and are frequently described as preliminary.
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
Early work on this family of molecules examined fractions of human gastric juice, where a larger protein was reported to protect gastrointestinal tissue in animal models. BPC 157 was designed as a shorter, more stable fragment of that protein and then studied on its own. The peptide itself is not a normal dietary component and is not present in the human body in meaningful quantities. Descriptions of its origin therefore refer to the research lineage of a laboratory molecule rather than to an endogenous or nutritional substance.
The sequence contains an unusually high proportion of proline and glycine, which limits regular secondary structure and contributes to solubility in aqueous media. The compound dissolves readily in water and in normal saline. Because it is a peptide, digestive enzymes are expected to break it down if it is swallowed, a consideration that influences the routes of administration used in animal experiments. Detailed conformational data remain limited, and published structural models are largely computational.
| Property | Value | Notes |
|---|---|---|
| Typical subjects | Rats and mice | Animal models |
| Common routes | Injection and oral | Route varies by study |
| Reported dose range | Microgram to milligram per kg | Not standardized across work |
| Frequent endpoints | Tissue repair, angiogenesis | Marker-dependent |
| Human evidence | Limited | Mostly small or preliminary studies |
BPC-157 is a synthetic pentadecapeptide whose sequence is commonly given as Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is described in the literature as a fragment of a larger protein found in human gastric juice, referred to as body protection compound. The peptide was first characterized in the early 1990s by a research group in Zagreb, Croatia. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Supplied material is typically a lyophilized white to off-white powder. The peptide is freely soluble in water and in common aqueous buffers, which allows it to be handled as a stock solution. Because the sequence contains no cysteine, disulfide cross-linking is not a route of degradation. The absence of aromatic residues means ultraviolet absorbance at 280 nm is minimal, so quantification usually relies on peptide bond absorbance near 214 nm or on amino acid analysis.
Common synonyms in catalogs include pentadecapeptide BPC 157, BPC157, and the full sequence name. A CAS registry number in the 137525-51-0 range is frequently listed, though the assignment should be verified against the supplier certificate of analysis. The name itself is not a pharmacopoeial designation, and there is no standardized international nonproprietary name. Distinguishing genuine material from related fragments generally requires mass spectrometry, since several truncated sequences share similar chromatographic behavior.
Lyophilized peptide is normally kept at minus twenty degrees Celsius or colder, away from light and moisture. Powder held under those conditions is widely treated as stable for long periods, although published stability studies for this exact sequence are sparse and often come from suppliers rather than independent laboratories. Once dissolved, solutions are generally handled cold and used within a short window, because peptide bonds can hydrolyze over time. Repeated freeze-thaw cycles are usually avoided to limit losses, and exact shelf-life figures depend on the buffer and the concentration involved.
Purity is ordinarily reported as a percentage from reverse-phase high-performance liquid chromatography, where the area of the main peak is compared with the total peak area. Identity is confirmed by mass spectrometry, since the measured mass can be checked against the value calculated from the sequence. Some certificates also include amino acid analysis or sequence confirmation by tandem mass spectrometry. A single purity number does not describe the profile of related impurities, so the underlying chromatogram and spectrum usually carry more information than the headline figure.
Material of this kind is sold for laboratory research, and labels typically state that it is not intended for human or veterinary use. In many countries it is not an approved medicine, and sports antidoping rules place it among prohibited non-approved substances. Buyers commonly review a certificate of analysis, an independent test report, and the declared storage conditions. Batch-to-batch variation in purity and in counterion content is possible, and how much that variation affects experimental outcomes remains an open question.
== Pharmacokinetics == With the once-monthly formulation of paliperidone palmitate, the time to peak is 13 days and the elimination half-life is 25 to 49 days; for the 3-month formulation, the time to peak is 30 to 33 days and the half-life is 84 to 95 days (deltoid muscle) or 118 to 139 days (gluteal). These data come from a 2021 review whose authors included employees of Janssen Research & Development, the manufacturer of paliperidone palmitate. The peak-to-trough ratio of paliperidone palmitate at steady state ranges from 1.56 to 1.70 with the 1- and 3-month formulations. No pharmacokinetic data for the 6-month formulation has been released as of January 2021. However, a 2025 case report described a patient who still had measurable plasma paliperidone concentrations in the low therapeutic range 886 days (2.5 years) after her last injection, indicating that in some individuals the drug may be released from the depot far longer than the predicted half‑life. The pharmacokinetic profile was originally derived from a 2009 pooled analysis of 18,530 paliperidone concentration samples from 1,795 subjects across six Phase I trials and five Phase II and III trials funded by Johnson & Johnson Pharmaceutical Research and Development, LLC. Invega Sustenna, Invega Trinza, and Invega Hafyera all utilize nanoparticle technology. The NanoCrystal® technology used in all three long-acting paliperidone products is manufactured by Alkermes plc.
== Animal models == Current research on synthetic platelets primarily in preclinical phases of clinical trials, relying on animal models to test their safety, efficacy, and hemostatic performance in relevant therapeutic areas. In one study, researchers evaluated the efficacy of platelet-mimicking procoagulant nanoparticles (PPNs) using various animal models. In a mouse model of thrombocytopenia, induced by administering an anti-CD42b antibody to reduce platelet counts, PPNs were introduced and demonstrated a reduction in bleeding comparable to that achieved with syngeneic platelet transfusions. Additionally, in a rat model of acute liver injury and a mouse model of hemorrhagic trauma, treatment with PPNs led to decreased blood loss and improved survival rates compared to control groups receiving saline or control nanoparticles. These findings suggest that PPNs effectively mimic natural platelet functions, enhancing hemostasis in scenarios of significant bleeding.
=== Prostate conditions === Spironolactone has been studied at a high dosage in the treatment of benign prostatic hyperplasia (BPH; enlarged prostate). It was found to be better than placebo in terms of symptom relief following three months of treatment. However, this was not maintained after six months of treatment, by which point the improvements had largely disappeared. Moreover, no difference was observed between spironolactone and placebo with regard to volume of residual urine or prostate size. Gynecomastia was observed in about 5% of people. On the basis of these results, it has been said that spironolactone has no place in the treatment of BPH. Spironolactone has been studied and used limitedly in the treatment of prostate cancer.
A Moscow court ordered the arrests of film producer Alexander Rodnyansky and theatre director Ivan Vyrypaev for "spreading false information" about the Russian army, with Vyrypaev additionally being placed on the Russian federal wanted list by the Interior Ministry. Both individuals had been living in exile for their opposition to the war in Ukraine. Another court sentenced opposition figure and anti-war activist Mikhail Krieger to seven years in prison on charges of justifying terrorism and inciting hatred with the threat of violence prior to the invasion. Prior to his sentencing, Krieger said that he was being prosecuted for his "anti-war and now openly pro-Ukrainian position". During a summit in Iceland, the Council of Europe approved a "Register of Damage" to document actions of Russian forces in Ukraine for future claims of compensation against Russia. The United States, which attended the summit as an observer, Canada and Japan also supported the register.
Sources: en.wikipedia.org
== Honours and awards == In the 2020 New Year Honours, Heffernan was appointed a Companion of the New Zealand Order of Merit, for services to health. On her appointment, Heffernan asked New Zealanders to play their part to reduce antibiotic resistance, saying, "While antibiotics are essential medicines to treat bacterial infections, we overuse and misuse them and this contributes to resistance". On her retirement in 2018, after a 43-year career, ESR awarded Heffernan their Lifetime Achievement Award.
== Red blood cell modifications (secondary processing) == Red blood cell concentrates are sometimes modified to address specific needs of patients who, for different reasons, are unable to tolerate standard red blood cell concentrates.
== Outlook == Individuals with coeliac disease have a higher risk of developing cancer in certain parts of the gastrointestinal tract (oropharynx, oesophagus, and small intestine) compared to those without the disease. Small intestinal lymphoma is the most common cancer caused by complications of coeliac disease; however, it is still considered a rare complication. The prognosis for enteropathy‐associated T‐cell lymphoma (EATL) is poor with low survival rates. Risk factors for developing cancer among those with coeliac disease include older age and refractory coeliac disease. Coeliac disease also increases mortality risk; however, the extent of the increase is inconsistent across research.
Sources: en.wikipedia.org
Modified Adenine N6-carbamoyl-methyladenine N6-methyadenine Modified Guanine 7-Deazaguanine 7-Methylguanine Modified Cytosine N4-Methylcytosine 5-Carboxylcytosine 5-Formylcytosine 5-Glycosylhydroxymethylcytosine 5-Hydroxycytosine 5-Methylcytosine Modified Thymidine α-Glutamythymidine α-Putrescinylthymine Uracil and modifications Base J Uracil 5-Dihydroxypentauracil 5-Hydroxymethyldeoxyuracil Others Deoxyarchaeosine 2,6-Diaminopurine (2-Aminoadenine)
The Springboks had fulfilled all of their touring commitments through the Fifties and Sixties but the oppressive, claustrophobic political pressures overwhelmed them during the Seventies. They have not been able to play in Britain, Ireland, France or Australia since 1974, and their only major tour abroad in the last ten years to New Zealand in 1981, was full of controversy, and mass demonstrations. There is no doubt that giant steps have been taken to make Rugby totally integrated in South Africa in recent years, and their supporters feel that no sooner have they fulfilled the conditions required of them by world opinion than the goalposts are moved. Their opponents, who are against having any sporting links with a country which practises apartheid, accept that sport in South Africa has become increasingly integrated but claim it is impossible to have normal sport in an abnormal society.
subcellular localization 1. The subdivision of the interior of a cell into functionally distinct spaces or compartments (e.g. membrane-bound organelles) and the delegation of particular cellular functions and activities to these particular spaces. 2. The determination by any of various laboratory methods (e.g. fluorescent labelling) of the precise location(s) within a cell where a specific molecule has occupancy, or at which a specific activity occurs.
Sources: en.wikipedia.org
Human data are limited. Most evidence comes from animal experiments and from small or uncontrolled reports. The absence of large trials means clinical effects and safety are not firmly established.
Frequently measured outcomes include wound healing, blood vessel growth, and tissue repair markers. Some work examines gastrointestinal protection. The choice of endpoint depends on the model used.
Different routes of administration and different animal models require different amounts. Studies also use varied timelines and measurement methods. This variation makes it difficult to combine results into a single standardized figure.
It is a synthetic peptide. Its design was inspired by a fragment of a protein found in human gastric juice, but the fifteen-amino-acid molecule itself is made in a laboratory and is not a normal component of food or of human tissue in appreciable amounts.